Which has higher earnings & valuation, DXCM or MCK?

McKesson has higher revenue and earnings than DexCom. McKesson is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DexCom $4.66B 5.71 $836.30M $2.34 29.47 McKesson $403.43B 0.22 $4.76B $38.47 19.85

Is DXCM or MCK more profitable?

DexCom has a net margin of 19.31% compared to McKesson's net margin of 1.18%. DexCom's return on equity of 33.33% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets DexCom 19.31% 33.33% 13.19% McKesson 1.18% -345.35% 5.85%

Does the media prefer DXCM or MCK?

In the previous week, McKesson had 3 more articles in the media than DexCom. MarketBeat recorded 31 mentions for McKesson and 28 mentions for DexCom. McKesson's average media sentiment score of 1.32 beat DexCom's score of 1.03 indicating that McKesson is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DexCom 18 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive McKesson 26 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, MCK or HQY?

McKesson has higher revenue and earnings than HealthEquity. McKesson is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio McKesson $403.43B 0.22 $4.76B $38.47 19.85 HealthEquity $1.34B 5.33 $215.20M $2.67 31.94

Is MCK or HQY more profitable?

HealthEquity has a net margin of 17.25% compared to McKesson's net margin of 1.18%. HealthEquity's return on equity of 14.75% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets McKesson 1.18% -345.35% 5.85% HealthEquity 17.25% 14.75% 9.22%

Does the media favor MCK or HQY?

In the previous week, McKesson had 26 more articles in the media than HealthEquity. MarketBeat recorded 31 mentions for McKesson and 5 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.60 beat McKesson's score of 1.32 indicating that HealthEquity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment McKesson 26 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive HealthEquity 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has preferable earnings and valuation, MCK or HSIC?

McKesson has higher revenue and earnings than Henry Schein. McKesson is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio McKesson $403.43B 0.22 $4.76B $38.47 19.85 Henry Schein $13.38B 0.68 $398M $3.31 24.18

Is MCK or HSIC more profitable?

Henry Schein has a net margin of 2.95% compared to McKesson's net margin of 1.18%. Henry Schein's return on equity of 15.44% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets McKesson 1.18% -345.35% 5.85% Henry Schein 2.95% 15.44% 5.53%

Does the media refer more to MCK or HSIC?

In the previous week, McKesson had 24 more articles in the media than Henry Schein. MarketBeat recorded 31 mentions for McKesson and 7 mentions for Henry Schein. McKesson's average media sentiment score of 1.32 beat Henry Schein's score of 0.85 indicating that McKesson is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment McKesson 26 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Henry Schein 5 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor MCK or MMSI?

In the previous week, McKesson had 27 more articles in the media than Merit Medical Systems. MarketBeat recorded 31 mentions for McKesson and 4 mentions for Merit Medical Systems. McKesson's average media sentiment score of 1.32 beat Merit Medical Systems' score of 1.25 indicating that McKesson is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment McKesson 26 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Merit Medical Systems 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor AMN or MCK?

In the previous week, McKesson had 17 more articles in the media than AMN Healthcare Services. MarketBeat recorded 31 mentions for McKesson and 14 mentions for AMN Healthcare Services. McKesson's average media sentiment score of 1.32 beat AMN Healthcare Services' score of 0.31 indicating that McKesson is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AMN Healthcare Services 3 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral McKesson 26 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

McKesson (MCK) Competitors

$763.60 +18.75 (+2.52%)

As of 03:52 PM Eastern

Compare

MCK vs. DXCM, HQY, HSIC, MMSI, and AMN

Should you buy McKesson stock or one of its competitors? MarketBeat compares McKesson with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with McKesson include DexCom (DXCM), HealthEquity (HQY), Henry Schein (HSIC), Merit Medical Systems (MMSI), and AMN Healthcare Services (AMN). These companies are all part of the "medical" sector.

How does McKesson compare to DexCom?

DexCom (NASDAQ:DXCM) and McKesson (NYSE:MCK) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment.

In the previous week, McKesson had 3 more articles in the media than DexCom. MarketBeat recorded 31 mentions for McKesson and 28 mentions for DexCom. McKesson's average media sentiment score of 1.32 beat DexCom's score of 1.03 indicating that McKesson is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DexCom	18 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
McKesson	26 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

McKesson has higher revenue and earnings than DexCom. McKesson is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DexCom	$4.66B	5.71	$836.30M	$2.34	29.47
McKesson	$403.43B	0.22	$4.76B	$38.47	19.85

DexCom has a beta of 1.45, suggesting that its share price is 45% more volatile than the broader market. Comparatively, McKesson has a beta of 0.31, suggesting that its share price is 69% less volatile than the broader market.

DexCom has a net margin of 19.31% compared to McKesson's net margin of 1.18%. DexCom's return on equity of 33.33% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DexCom	19.31%	33.33%	13.19%
McKesson	1.18%	-345.35%	5.85%

DexCom currently has a consensus price target of $84.88, indicating a potential upside of 23.09%. McKesson has a consensus price target of $960.53, indicating a potential upside of 25.79%. Given McKesson's higher possible upside, analysts clearly believe McKesson is more favorable than DexCom.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DexCom	1 Sell rating(s)	3 Hold rating(s)	21 Buy rating(s)	2 Strong Buy rating(s)	2.89
McKesson	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82

97.8% of DexCom shares are owned by institutional investors. Comparatively, 85.1% of McKesson shares are owned by institutional investors. 0.3% of DexCom shares are owned by insiders. Comparatively, 0.1% of McKesson shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

DexCom beats McKesson on 11 of the 17 factors compared between the two stocks.

How does McKesson compare to HealthEquity?

McKesson (NYSE:MCK) and HealthEquity (NASDAQ:HQY) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, media sentiment, analyst recommendations, dividends, earnings and profitability.

McKesson has a beta of 0.31, indicating that its share price is 69% less volatile than the broader market. Comparatively, HealthEquity has a beta of 0.21, indicating that its share price is 79% less volatile than the broader market.

In the previous week, McKesson had 26 more articles in the media than HealthEquity. MarketBeat recorded 31 mentions for McKesson and 5 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.60 beat McKesson's score of 1.32 indicating that HealthEquity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	26 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
HealthEquity	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

HealthEquity has a net margin of 17.25% compared to McKesson's net margin of 1.18%. HealthEquity's return on equity of 14.75% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.18%	-345.35%	5.85%
HealthEquity	17.25%	14.75%	9.22%

85.1% of McKesson shares are held by institutional investors. Comparatively, 99.6% of HealthEquity shares are held by institutional investors. 0.1% of McKesson shares are held by company insiders. Comparatively, 1.6% of HealthEquity shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

McKesson has higher revenue and earnings than HealthEquity. McKesson is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.22	$4.76B	$38.47	19.85
HealthEquity	$1.34B	5.33	$215.20M	$2.67	31.94

McKesson currently has a consensus target price of $960.53, indicating a potential upside of 25.79%. HealthEquity has a consensus target price of $110.57, indicating a potential upside of 29.66%. Given HealthEquity's stronger consensus rating and higher probable upside, analysts plainly believe HealthEquity is more favorable than McKesson.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.86

Summary

HealthEquity beats McKesson on 11 of the 17 factors compared between the two stocks.

How does McKesson compare to Henry Schein?

McKesson (NYSE:MCK) and Henry Schein (NASDAQ:HSIC) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, media sentiment, valuation, dividends, risk and profitability.

85.1% of McKesson shares are owned by institutional investors. Comparatively, 96.6% of Henry Schein shares are owned by institutional investors. 0.1% of McKesson shares are owned by insiders. Comparatively, 0.9% of Henry Schein shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

McKesson currently has a consensus target price of $960.53, suggesting a potential upside of 25.79%. Henry Schein has a consensus target price of $87.85, suggesting a potential upside of 9.75%. Given McKesson's stronger consensus rating and higher possible upside, equities research analysts plainly believe McKesson is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82
Henry Schein	1 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.43

Henry Schein has a net margin of 2.95% compared to McKesson's net margin of 1.18%. Henry Schein's return on equity of 15.44% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.18%	-345.35%	5.85%
Henry Schein	2.95%	15.44%	5.53%

McKesson has higher revenue and earnings than Henry Schein. McKesson is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.22	$4.76B	$38.47	19.85
Henry Schein	$13.38B	0.68	$398M	$3.31	24.18

In the previous week, McKesson had 24 more articles in the media than Henry Schein. MarketBeat recorded 31 mentions for McKesson and 7 mentions for Henry Schein. McKesson's average media sentiment score of 1.32 beat Henry Schein's score of 0.85 indicating that McKesson is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	26 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Henry Schein	5 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

McKesson has a beta of 0.31, indicating that its stock price is 69% less volatile than the broader market. Comparatively, Henry Schein has a beta of 0.82, indicating that its stock price is 18% less volatile than the broader market.

Summary

McKesson beats Henry Schein on 9 of the 16 factors compared between the two stocks.

How does McKesson compare to Merit Medical Systems?

McKesson (NYSE:MCK) and Merit Medical Systems (NASDAQ:MMSI) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, valuation, risk, profitability and institutional ownership.

McKesson has higher revenue and earnings than Merit Medical Systems. McKesson is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.22	$4.76B	$38.47	19.85
Merit Medical Systems	$1.54B	2.59	$128.49M	$2.31	28.99

Merit Medical Systems has a net margin of 9.03% compared to McKesson's net margin of 1.18%. Merit Medical Systems' return on equity of 13.54% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.18%	-345.35%	5.85%
Merit Medical Systems	9.03%	13.54%	7.94%

McKesson has a beta of 0.31, meaning that its stock price is 69% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.54, meaning that its stock price is 46% less volatile than the broader market.

McKesson currently has a consensus price target of $960.53, indicating a potential upside of 25.79%. Merit Medical Systems has a consensus price target of $92.80, indicating a potential upside of 38.59%. Given Merit Medical Systems' higher probable upside, analysts clearly believe Merit Medical Systems is more favorable than McKesson.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82
Merit Medical Systems	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.64

85.1% of McKesson shares are held by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are held by institutional investors. 0.1% of McKesson shares are held by insiders. Comparatively, 0.7% of Merit Medical Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, McKesson had 27 more articles in the media than Merit Medical Systems. MarketBeat recorded 31 mentions for McKesson and 4 mentions for Merit Medical Systems. McKesson's average media sentiment score of 1.32 beat Merit Medical Systems' score of 1.25 indicating that McKesson is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	26 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Merit Medical Systems	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Merit Medical Systems beats McKesson on 9 of the 16 factors compared between the two stocks.

How does McKesson compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and McKesson (NYSE:MCK) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, profitability, earnings, risk, institutional ownership and analyst recommendations.

AMN Healthcare Services currently has a consensus target price of $27.00, indicating a potential downside of 12.79%. McKesson has a consensus target price of $960.53, indicating a potential upside of 25.79%. Given McKesson's stronger consensus rating and higher possible upside, analysts clearly believe McKesson is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22
McKesson	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82

AMN Healthcare Services has a beta of 0.44, indicating that its share price is 56% less volatile than the broader market. Comparatively, McKesson has a beta of 0.31, indicating that its share price is 69% less volatile than the broader market.

McKesson has a net margin of 1.18% compared to AMN Healthcare Services' net margin of -0.95%. AMN Healthcare Services' return on equity of 18.01% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	-0.95%	18.01%	5.19%
McKesson	1.18%	-345.35%	5.85%

McKesson has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$2.73B	0.44	-$95.70M	-$0.87	N/A
McKesson	$403.43B	0.22	$4.76B	$38.47	19.85

99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 85.1% of McKesson shares are owned by institutional investors. 1.1% of AMN Healthcare Services shares are owned by insiders. Comparatively, 0.1% of McKesson shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, McKesson had 17 more articles in the media than AMN Healthcare Services. MarketBeat recorded 31 mentions for McKesson and 14 mentions for AMN Healthcare Services. McKesson's average media sentiment score of 1.32 beat AMN Healthcare Services' score of 0.31 indicating that McKesson is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AMN Healthcare Services	3 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
McKesson	26 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

McKesson beats AMN Healthcare Services on 11 of the 16 factors compared between the two stocks.

Get McKesson News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MCK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MCK vs. The Competition

Export

Metric	McKesson	MED/DENTAL Industry	Medical Sector	NYSE Exchange
Market Cap	$89.40B	$14.97B	$6.47B	$23.13B
Dividend Yield	0.44%	1.35%	2.68%	4.06%
P/E Ratio	19.85	18.11	24.67	31.09
Price / Sales	0.22	2.16	518.45	20.82
Price / Cash	16.47	13.76	27.92	18.65
Price / Book	-52.63	3.24	10.83	4.66
Net Income	$4.76B	$534.24M	$3.56B	$1.07B
7 Day Performance	-2.92%	-0.81%	1.75%	-1.06%
1 Month Performance	-0.22%	1.77%	0.51%	0.17%
1 Year Performance	5.70%	1.44%	32.92%	24.36%

McKesson Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MCK McKesson	4.9373 of 5 stars	$763.60 +2.5%	$960.53 +25.8%	+3.4%	$89.40B	$403.43B	19.85	43,000	Positive News Gap Up
DXCM DexCom	4.7595 of 5 stars	$74.22 -1.5%	$84.83 +14.3%	-13.7%	$28.64B	$4.82B	31.72	11,000	Positive News Analyst Forecast
HQY HealthEquity	4.8662 of 5 stars	$86.97 -1.6%	$110.57 +27.1%	-16.5%	$7.27B	$1.31B	32.57	2,814	Positive News
HSIC Henry Schein	3.8831 of 5 stars	$81.09 -0.2%	$87.85 +8.3%	+9.3%	$9.24B	$13.18B	24.50	25,000	Positive News
MMSI Merit Medical Systems	4.4702 of 5 stars	$66.94 +0.6%	$92.80 +38.6%	-27.7%	$3.99B	$1.52B	28.98	7,500	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:MCK) was last updated on 6/23/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

McKesson (MCK) Competitors

MCK vs. DXCM, HQY, HSIC, MMSI, and AMN

How does McKesson compare to DexCom?

Summary

How does McKesson compare to HealthEquity?

Summary

How does McKesson compare to Henry Schein?

Summary

How does McKesson compare to Merit Medical Systems?

Summary

How does McKesson compare to AMN Healthcare Services?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MCK vs. The Competition

McKesson Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

McKesson (MCK) Competitors

MCK vs. DXCM, HQY, HSIC, MMSI, and AMN

How does McKesson compare to DexCom?

Does the media prefer DXCM or MCK?

Which has higher earnings & valuation, DXCM or MCK?

Which has more risk and volatility, DXCM or MCK?

Is DXCM or MCK more profitable?

Do analysts recommend DXCM or MCK?

Do institutionals & insiders believe in DXCM or MCK?

Summary

How does McKesson compare to HealthEquity?

Which has more risk and volatility, MCK or HQY?

Does the media favor MCK or HQY?

Is MCK or HQY more profitable?

Do insiders & institutionals believe in MCK or HQY?

Which has stronger earnings & valuation, MCK or HQY?

Do analysts rate MCK or HQY?

Summary

How does McKesson compare to Henry Schein?

Do insiders & institutionals have more ownership in MCK or HSIC?

Do analysts recommend MCK or HSIC?

Is MCK or HSIC more profitable?

Which has preferable earnings and valuation, MCK or HSIC?

Does the media refer more to MCK or HSIC?

Which has more risk & volatility, MCK or HSIC?

Summary

How does McKesson compare to Merit Medical Systems?

Which has stronger earnings and valuation, MCK or MMSI?

Is MCK or MMSI more profitable?

Which has more risk & volatility, MCK or MMSI?

Do analysts prefer MCK or MMSI?

Do insiders & institutionals hold more shares of MCK or MMSI?

Does the media favor MCK or MMSI?

Summary

How does McKesson compare to AMN Healthcare Services?

Do analysts rate AMN or MCK?

Which has more risk & volatility, AMN or MCK?

Is AMN or MCK more profitable?

Which has higher valuation and earnings, AMN or MCK?

Do insiders and institutionals have more ownership in AMN or MCK?

Does the media favor AMN or MCK?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MCK vs. The Competition

McKesson Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools